Background: In developing countries, clinical profile based empirical treatment is practiced for treating pediatric scrub typhus cases. Knowledge on pattern of symptoms and signs will help in early initiation of specific treatment. This study was aimed to describe clinical profile and trends in admissions of pediatric scrub typhus cases in a tertiary teaching hospital.Methods: A record based cross sectional descriptive study was conducted among all clinically diagnosed scrub typhus pediatric (<13 years of age) cases admitted between 1st January 2011 and 31st December 2014 in a tertiary teaching hospital, South India. Data on symptoms, signs, laboratory findings, treatment and outcome were extracted from clinical case records. Data were entered and analyzed using Epi Data software.Results: Of the total 228 cases, 124 (54.4%) were males, 131 (57.4%) were less than five years of age and 88% were from rural areas. Fever (100%), vomiting (61.2%) and cough (54.8%) were the most common symptoms. Hepatomegaly (88.6%), splenomegaly (64.5%), lymphadenopathy (48.7%), edema (43.4%) and eschar (38.6%) were the common signs observed. Anemia was present in 122 (59.8%) and thrombocytopenia in 75 (33.3%) children. Only one child (0.4%) died. There was an increasing trend in proportion of scrub typhus cases to overall admissions from 1% to 2.2% over four-year period (2011-2014). More cases were admitted between the months of September and January. Conclusions:Scrub typhus contributed to significant pediatric admissions in the tertiary care centre with an increase in cases over years. Treatment with doxycycline or azithromycin showed good response and mortality was very low
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.